CCM

Camber Capital Management Portfolio holdings

AUM $718M
1-Year Return 4.23%
This Quarter Return
+12.51%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.53B
AUM Growth
+$332M
Cap. Flow
+$150M
Cap. Flow %
9.78%
Top 10 Hldgs %
64.78%
Holding
37
New
12
Increased
6
Reduced
7
Closed
3

Top Buys

1
AGN
Allergan plc
AGN
$98.1M
2
UHS icon
Universal Health Services
UHS
$88.4M
3
GSK icon
GSK
GSK
$53.2M
4
MDCO
Medicines Co
MDCO
$43.7M
5
HCA icon
HCA Healthcare
HCA
$39.5M

Top Sells

1
NKTR icon
Nektar Therapeutics
NKTR
$110M
2
PRGO icon
Perrigo
PRGO
$82.5M
3
SRPT icon
Sarepta Therapeutics
SRPT
$61.2M
4
OFIX icon
Orthofix Medical
OFIX
$47.9M
5
GILD icon
Gilead Sciences
GILD
$40.5M

Sector Composition

1 Healthcare 82.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ATRA icon
26
Atara Biotherapeutics
ATRA
$89.9M
$9.69M 0.47%
21,420
– –
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$9.03M 0.44%
+1,000,000
New +$9.03M
OPCH icon
28
Option Care Health
OPCH
$4.67B
$7.39M 0.36%
635,050
-940,000
-60% -$10.9M
PRTA icon
29
Prothena Corp
PRTA
$442M
$4.69M 0.23%
+125,000
New +$4.69M
MNK
30
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.37M 0.12%
+105,000
New +$2.37M
SGRY icon
31
Surgery Partners
SGRY
$2.87B
$1.64M 0.08%
+135,084
New +$1.64M
EXAS icon
32
Exact Sciences
EXAS
$9.73B
– –
0
– –
GILD icon
33
Gilead Sciences
GILD
$140B
– –
-500,000
Closed -$40.5M
PRGO icon
34
Perrigo
PRGO
$3.2B
– –
-975,000
Closed -$82.5M
SPY icon
35
SPDR S&P 500 ETF Trust
SPY
$662B
– –
0
– –
TEVA icon
36
Teva Pharmaceuticals
TEVA
$21.2B
– –
0
– –
BIOL
37
DELISTED
Biolase, Inc.
BIOL
– –
-427
Closed -$3.21M
1
2